# Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

> **NCT04489160** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 106 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Trauma, Head

## Interventions

- **DRUG:** C1 Inhibitor, Human
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04489160
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-25
- **Primary completion:** 2023-07
- **Final completion:** 2024-07
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2021-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489160, "Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04489160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*